Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 8, 2008, Pages 559-566

  Mojiminiyi, Olusegun A ^a   Marouf, Rajaa ^a   Abdella, Nabila A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Anemia; Ferritin; Iron; Metabolic syndrome; Soluble transferrin receptor; Type 2 diabetes mellitus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; FERRITIN; IRON;

ADIPOSE TISSUE; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; ENZYMOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOLOGY; HUMAN; INFORMED CONSENT; KUWAIT; MENOPAUSE; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADIPOSE TISSUE; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; HUMANS; INFORMED CONSENT; IRON; KUWAIT; MENOPAUSE; METABOLIC SYNDROME X;

EID: 51249096123     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.07.007     Document Type: Article

References (30)

1. Oberley L.W. Free radicals and diabetes. Free Radic Biol Med 5 (1988) 113-124
2. Wolff S.P. Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49 (1993) 642-652
3. Merkel P.A., Simonson D.C., Amiel S.A., Plewe G., Sherwin R.S., Pearson H.A., et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 318 (1988) 809-814
4. Fernandez-Real J.M., Lopez-Bermejo A., and Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 51 (2002) 2348-2354
5. Salonen J.T., Nyyssonen K., Korpela H., Korpela H., Tuomilehto J., Seppanen R., et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 (1992) 803-811
6. Sullivan J.L. Iron therapy and cardiovascular disease. Kidney Int 69 (1999) S135-S137
7. Jehn M., Clark J.M., and Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27 (2004) 2422-2428
8. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
9. Ridker P.M., Brown N.J., Vaughan D.E., Harrison D.G., and Mehta J.L. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 (2004) IV6-IV19
10. Mojiminiyi O.A., Abdella N.A., Zaki M.Y., El Gebely S.A., Mohamedi H.M., and Aldhahi W.A. Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus. Diabet Med 23 (2006) 839-844
11. Bosman D.R., Winkler A.S., Marsden J.T., Macdougall I.C., and Watkins P.J. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 24 (2001) 495-499
12. Thomas M.C., Tsalamandris C., Macisaac R., and Jerums G. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia. Diabet Med 23 (2006) 502-509
13. Skikne B.S., Flowers C.H., and Cook J.D. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75 (1990) 1870-1876
14. Punnonen K., Irjala K., and Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89 (1997) 1052-1057
15. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
16. Iwasaki T., Nakajima A., Yoneda M., Yamada Y., Mukasa K., Fujita K., et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 28 (2005) 2486-2491
17. Levey A.S., Bosch J.P., Breyer Lewis J., Greene T., Rogers N., Roth D., and for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
18. Diabetes Trials Unit (2004), Oxford, URL. http://www.dtu.ox.ac.uk/index.html?maindoc=/publications/ HOMA Calculator v2.2 [Accessed March 22 2005]
19. Friedewald W.T., Levy R.T., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 499-502
20. American Diabetes Association Standards of Medical Care in Diabetes. Diabetes Care 28 (2005) S4-36
21. Thomas C., and Thomas L. Biochemical and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 48 (2002) 1066-1076
22. Blackburn H. Electrocardiographic classification for population comparisons. The Minnesota code. J Electrocardiol 52 (1969) 5-9
23. Rose G.A. The diagnosis of 'ischaemic' heart pain and intermittent claudication in field surveys. Bull World Health Organ 27 (1962) 645-658
24. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
25. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
26. Salonen J.T., Tuomainen T.P., Nyyssönen K., Lakka H.M., and Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. Brit Med J 12 (1998) 727
27. Ford E.S., and Cogswell M.E. Diabetes and serum ferritin concentrations among US adults. Diabetes Care 22 (1999) 1978-1983
28. Sullivan J.L. Interactions of stored iron with traditional and inflammatory cardiovascular risk factors. Atherosclerosis 167 (2003) 169
29. Sullivan J. Is stored iron safe?. J Lab Clin Med 144 (2004) 280-284
30. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1 8233 (1981) 1293-1294